Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:47 PM
NCT ID:
NCT04684394
Pre Assignment Details:
A total of 70 participants were screened of which 20 were screen failure. 50 participants were randomized in 2:1 ratio in this study, of which 34 participants received the GEM103 + aflibercept (SoC) and 16 received the Sham + SoC.
Recruitment Details:
This study was conducted at multiple sites in the United States from 29 December 2020 to 18 February 2022.
Type Units Analyzed:
eyes
Study:
NCT04684394
Study Brief:
Results Section:
NCT04684394